Operative Behandlungsoptionen von Knochenmetastasen

Chapter

Zusammenfassung

Bei Patienten mit Knochenmetastasen ist in den meisten Fällen ein kurativer Therapieansatz nicht zielführend. Falls eine palliative, operative Intervention nötig ist, sollte ein risikoarmer, technisch einfacher und kurzer Eingriff gewählt werden. Von diesem Grundsatz ausgenommen sind solitäre Metastasen von primären Tumoren mit guter Prognose. Hier sollte eine R0-Resektion angestrebt werden. Dies trifft insbesondere für Spätmetastasen zu. In diesem Kapitel werden die Indikationen zur operativen Therapie bei Skelettmetastasen dargestellt. Außerdem werden Vor- und Nachteile der einzelnen operativen Techniken erörtert.

Literatur

  1. Abrams J, Doyle LA, Aisner J (1988) Staging, prognostic factors, and special considerations in small cell lung cancer. Semin Oncol 15: 261–277PubMedGoogle Scholar
  2. Bartels RH, Feuth T, van der Maazen R et al (2007) Development of a model with which to predict the life expectancy of patients with spinal epidural metastasis. Cancer 110: 2042–2049PubMedCrossRefGoogle Scholar
  3. Bartels RH, Feuth T, Rades D et al (2011) External validation of a model to predict the survival of patients presenting with a spinal epidural metastasis. Cancer Metastasis Rev 30: 153–159PubMedCrossRefGoogle Scholar
  4. Bauer HC, Wedin R (1995) Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients. Acta Orthop Scand 66: 143–146PubMedCrossRefGoogle Scholar
  5. Bickels J, Dadia S, Lidar Z (2009) Surgical management of metastatic bone disease. J Bone Joint Surg Am 91: 1503–1516PubMedCrossRefGoogle Scholar
  6. Biewener A, Meyer J, Rentsch C et al (2007) Internal fixation of meta- and diaphyseal intercalary bone defects after tumour resection with intramedullary nailing and porous polymethylmetacrylate (PMMA) spacer. Orthopade 36: 152–158, 160–153Google Scholar
  7. Bray F, Ren JS, Masuyer E, Ferlay J (2012) Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132(5): 1133–1145PubMedCrossRefGoogle Scholar
  8. Castillo LA, Yeh SD, Leeper RD, Benua RS (1980) Bone scans in bone metastases from functioning thyroid carcinoma. Clin Nucl Med 5: 200–209PubMedCrossRefGoogle Scholar
  9. Chow E, Harris K, Fung K (2006) Successful validation of a survival prediction model in patients with metastases in the spinal column. Int J Radiat Oncol Biol Phys 65: 1522–1527PubMedCrossRefGoogle Scholar
  10. Clayer M, Duncan W (2006) Importance of biopsy of new bone lesions in patients with previous carcinoma. Clin Orthop Relat Res 451: 208–211PubMedCrossRefGoogle Scholar
  11. Clemons MJ, Dranitsaris G, Ooi WS et al (2006) Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy. J Clin Oncol 24: 4895–4900PubMedCrossRefGoogle Scholar
  12. Coleman RE (1997) Skeletal complications of malignancy. Cancer 80: 1588–1594PubMedCrossRefGoogle Scholar
  13. Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27: 165–176PubMedCrossRefGoogle Scholar
  14. Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12: 6243s–6249sPubMedCrossRefGoogle Scholar
  15. Coleman RE, Rubens RD (1987) The clinical course of bone metastases from breast cancer. Br J Cancer 55: 61–66PubMedCentralPubMedCrossRefGoogle Scholar
  16. Damron TA, Morgan H, Prakash D et al (2003) Critical evaluation of Mirels’ rating system for impending pathologic fractures. Clin Orthop Relat Res (415 Suppl): S201–207Google Scholar
  17. Damron TA, Leerapun T, Hugate RR et al (2008) Does the second-generation intercalary humeral spacer improve on the first? Clin Orthop Relat Res 466: 1309–1317PubMedCentralPubMedCrossRefGoogle Scholar
  18. Doung YC, Kenan S, Rapp T (2011) Metastatic lesions of the proximal femur. Bull NYU Hosp Jt Dis 69: 81–86PubMedGoogle Scholar
  19. Ecker RD, Endo T, Wetjen NM et al (2005) Diagnosis and treatment of vertebral column metastases. Mayo Clin Proc 80: 1177–1186PubMedCrossRefGoogle Scholar
  20. Ferlay J, Shin HR, Bray F et al (2010) GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. http://globocan.iarc.fr (Lyon, France, International Agency for Research on Cancer)
  21. Finstein JL, King JJ, Fox EJ et al (2007) Bipolar proximal femoral replacement prostheses for musculoskeletal neoplasms. Clin Orthop Relat Res 459: 66–75PubMedCrossRefGoogle Scholar
  22. Forbes GS, McLeod RA, Hattery RR (1977) Radiographic manifestations of bone metastases from renal carcinoma. Am J Roentgenol 129: 61–66CrossRefGoogle Scholar
  23. Galasko CS (1981) The anatomy and pathways of skeletal metastases. In: Weiss L, Gilbert A (eds) Bone Metastases. GK Hall, Boston, MA, pp 49–63Google Scholar
  24. Georgy BA (2008) Metastatic spinal lesions: state-of-the-art treatment options and future trends. Am J Neuroradiol 29: 1605–1611PubMedCrossRefGoogle Scholar
  25. Hansen BH, Keller J, Laitinen M et al (2004) The Scandinavian Sarcoma Group Skeletal Metastasis Register. Survival after surgery for bone metastases in the pelvis and extremities. Acta Orthop Scand Suppl 75: 11–15PubMedCrossRefGoogle Scholar
  26. Harrington KD (1981) The management of acetabular insufficiency secondary to metastatic malignant disease. J Bone Joint Surg Am 63: 653–664PubMedGoogle Scholar
  27. Hessler C, Vettorazzi E, Madert J et al (2011) Actual and predicted survival time of patients with spinal metastases of lung cancer: evaluation of the robustness of the Tokuhashi score. Spine (Phila pa 1976) 36: 983–989Google Scholar
  28. Holzapfel BM, Prodinger PM, Hoberg M et al (2010) Periprosthetic fractures after total hip arthroplasty: classification, diagnosis and therapy strategies. Orthopade 39: 519–535PubMedCrossRefGoogle Scholar
  29. Holzapfel BM, Ludemann M, Holzapfel DE et al (2012a) Open biopsy of bone and soft tissue tumors : Guidelines for precise surgical procedures. Oper Orthop Traumatol 24: 403–417CrossRefGoogle Scholar
  30. Holzapfel BM, Pilge H, Toepfer A et al (2012b) Proximal tibial replacement and alloplastic reconstruction of the extensor mechanism after bone tumor resection. Oper Orthop Traumatol 24: 247–262CrossRefGoogle Scholar
  31. Kinkel S, Lehner B, Kleinhans JA et al (2010) Medium to long-term results after reconstruction of bone defects at the knee with tumor endoprostheses. J Surg Oncol 101: 166–169PubMedGoogle Scholar
  32. Leithner A, Radl R, Gruber G et al (2008) Predictive value of seven preoperative prognostic scoring systems for spinal metastases. Eur Spine J 17: 1488–1495PubMedCentralPubMedCrossRefGoogle Scholar
  33. Leithner A, Friesenbichler J, Andreou D et al (2012) Bone metastases treatment strategies. Orthopade 41: 863–871; quiz 872PubMedCrossRefGoogle Scholar
  34. Li S, Peng Y, Weinhandl ED et al (2012) Estimated number of prevalent cases of metastatic bone disease in the US adult population. Clin Epidemiol 4: 87–93PubMedCentralPubMedGoogle Scholar
  35. Melton LJ 3rd, Achenbach SJ, Atkinson EJ et al (2013) Long-term mortality following fractures at different skeletal sites: a population-based cohort study. Osteoporos Int 24: 1689–1696PubMedCentralPubMedCrossRefGoogle Scholar
  36. Menendez LR, Ahlmann ER, Kermani C, Gotha H (2006) Endoprosthetic reconstruction for neoplasms of the proximal femur. Clin Orthop Relat Res 450: 46–51PubMedCrossRefGoogle Scholar
  37. Mirels H (1989) Metastatic disease in long bones. A proposed scoring system for diagnosing impending pathologic fractures. Clin Orthop Relat Res (249): 256–264Google Scholar
  38. Nijs SJ, Broos PL, Van Cutsem E (2004) Treatment of a metastasis of a rectal carcinoma in the greater trochanter with the AO/ASIF Proximal Femoral Nail. A case report. Acta Chir Belg 104: 237–239PubMedGoogle Scholar
  39. Nozue M, Oshiro Y, Kurata M et al (2002) Treatment and prognosis in colorectal cancer patients with bone metastasis. Oncol Rep 9: 109–112PubMedGoogle Scholar
  40. Pilge H, Holzapfel BM, Prodinger PM et al (2011) Diagnostics and therapy of spinal metastases. Orthopade 40: 185–193; quiz 194–185Google Scholar
  41. Pointillart V, Vital JM, Salmi R et al (2011) Survival prognostic factors and clinical outcomes in patients with spinal metastases. J Cancer Res Clin Oncol 137: 849–856PubMedCrossRefGoogle Scholar
  42. Rudert M, Holzapfel BM, Pilge H et al (2012) Partial pelvic resection (internal hemipelvectomy) and endoprosthetic replacement in periacetabular tumors. Oper Orthop Traumatol 24: 196–214PubMedCrossRefGoogle Scholar
  43. Saad F, Lipton A, Cook R et al (2007) Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 110: 1860–1867PubMedCrossRefGoogle Scholar
  44. Sabbatini P, Larson SM, Kremer A et al (1999) Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. J Clin Oncol 17: 948–957PubMedGoogle Scholar
  45. Sciubba DM, Gokaslan ZL, Suk I et al (2007) Positive and negative prognostic variables for patients undergoing spine surgery for metastatic breast disease. Eur Spine J 16: 1659–1667PubMedCentralPubMedCrossRefGoogle Scholar
  46. Soloway MS, Hardeman SW, Hickey D et al (1988) Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer 61: 195–202PubMedCrossRefGoogle Scholar
  47. Taneichi H, Kaneda K, Takeda N et al (1997) Risk factors and probability of vertebral body collapse in metastases of the thoracic and lumbar spine. Spine (Phila pa 1976) 22: 239–245PubMedCrossRefGoogle Scholar
  48. Tillman RM, Myers GJ, Abudu AT et al (2008) The three-pin modified »Harrington« procedure for advanced metastatic destruction of the acetabulum. J Bone Joint Surg Br 90: 84–87PubMedCrossRefGoogle Scholar
  49. Tokuhashi Y, Matsuzaki H, Toriyama S et al (1990) Scoring system for the preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 15: 1110–1113PubMedCrossRefGoogle Scholar
  50. Tokuhashi Y, Matsuzaki H, Oda H et al (2005) A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila pa 1976) 30: 2186–2191PubMedCrossRefGoogle Scholar
  51. Tomita K, Kawahara N, Kobayashi T et al (2001) Surgical strategy for spinal metastases. Spine (Phila Pa 1976) 26: 298–306PubMedCrossRefGoogle Scholar
  52. Van der Linden YM, Dijkstra PD, Kroon HM et al (2004) Comparative analysis of risk factors for pathological fracture with femoral metastases. J Bone Joint Surg Br 86: 566–573Google Scholar
  53. Van der Linden YM, Dijkstra SP, Vonk EJ et al (2005) Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 103: 320–328CrossRefGoogle Scholar
  54. von Eisenhart-Rothe R, Gollwitzer H, Toepfer A et al (2010) Mega cups and partial pelvic replacement. Orthopade 39: 931–941CrossRefGoogle Scholar
  55. Vrionis FD, Small J (2003) Surgical management of metastatic spinal neoplasms. Neurosurg Focus 15: E12PubMedCrossRefGoogle Scholar
  56. Wachenfeld I, Sanner G, Bottcher HD, Kollath J (1996) The remineralization of the vertebral metastases of breast carcinoma after radiotherapy. Strahlenther Onkol 172: 332–341PubMedGoogle Scholar
  57. Ward, W.G., Holsenbeck, S., Dorey, F.J., Spang, J., and Howe, D. (2003) Metastatic disease of the femur: surgical treatment. Clin Orthop Relat Res, S230–244Google Scholar
  58. Wedin R, Bauer HC (2005) Surgical treatment of skeletal metastatic lesions of the proximal femur: endoprosthesis or reconstruction nail? J Bone Joint Surg Br 87: 1653–1657PubMedCrossRefGoogle Scholar
  59. Weinfurt KP, Trucco SM, Willke RJ, Schulman KA (2002) Measuring agreement between patient and proxy responses to multidimensional health-related quality-of-life measures in clinical trials. An application of psychometric profile analysis. J Clin Epidemiol 55: 608–618PubMedCrossRefGoogle Scholar
  60. Weinfurt KP, Castel LD, Li Y et al (2004) Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions. Med Care 42: 164–175PubMedCrossRefGoogle Scholar
  61. Woodward E, Jagdev S, McParland L et al (2011) Skeletal complications and survival in renal cancer patients with bone metastases. Bone 48: 160–166PubMedCrossRefGoogle Scholar
  62. Yamashita K, Denno K, Ueda T et al (1993) Prognostic significance of bone metastases in patients with metastatic prostate cancer. Cancer 71: 1297–1302PubMedCrossRefGoogle Scholar
  63. Yilmazlar S, Dogan S, Caner B et al (2008) Comparison of prognostic scores and surgical approaches to treat spinal metastatic tumors: a review of 57 cases. J Orthop Surg Res 3: 37PubMedCentralPubMedCrossRefGoogle Scholar
  64. Zekri J, Ahmed N, Coleman RE, Hancock BW (2001) The skeletal metastatic complications of renal cell carcinoma. Int J Oncol 19: 379–382PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  1. 1.Orthopädische Klinik König-Ludwig-HausLehrstuhl für Orthopädie der Julius-Maximilians-Universität WürzburgWürzburgDeutschland

Personalised recommendations